BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34517210)

  • 1. TUBA1C expression promotes proliferation by regulating the cell cycle and indicates poor prognosis in glioma.
    Gui S; Chen P; Liu Y; Chen Q; Cheng T; Lv S; Zhou T; Song Z; Xiao J; He W; Yuan S; Cheng Z
    Biochem Biophys Res Commun; 2021 Nov; 577():130-138. PubMed ID: 34517210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oncogenic role of tubulin alpha-1c chain in human tumours.
    Hu X; Zhu H; Chen B; He X; Shen Y; Zhang X; Xu Y; Xu X
    BMC Cancer; 2022 May; 22(1):498. PubMed ID: 35513790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of SOX9 indicates a better prognosis and inhibits the growth of glioma cells by inducing cell cycle arrest.
    Gao J; Zhang JY; Li YH; Ren F
    Int J Clin Exp Pathol; 2015; 8(9):10130-8. PubMed ID: 26617720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
    Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
    Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CKAP2L Knockdown Exerts Antitumor Effects by Increasing miR-4496 in Glioblastoma Cell Lines.
    Li YF; Tsai WC; Chou CH; Huang LC; Huang SM; Hueng DY; Tsai CK
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TUBA1C: a new potential target of LncRNA EGFR-AS1 promotes gastric cancer progression.
    Wang H; Cui H; Yang X; Peng L
    BMC Cancer; 2023 Mar; 23(1):258. PubMed ID: 36941595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1.
    Ma XL; Shang F; Ni W; Zhu J; Luo B; Zhang YQ
    J Cancer Res Clin Oncol; 2018 Dec; 144(12):2351-2366. PubMed ID: 30225541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RBM17 controls apoptosis and proliferation to promote Glioma progression.
    Lu J; Li Q; Cai L; Zhu Z; Guan J; Wang C; Xia J; Xia L; Wen M; Zheng W; Su Z; Wang C
    Biochem Biophys Res Commun; 2018 Oct; 505(1):20-28. PubMed ID: 30227940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel chromatin architectural regulator SND1 promotes glioma proliferation and invasion and predicts the prognosis of patients.
    Yu L; Xu J; Liu J; Zhang H; Sun C; Wang Q; Shi C; Zhou X; Hua D; Luo W; Bian X; Yu S
    Neuro Oncol; 2019 Jun; 21(6):742-754. PubMed ID: 30753603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.
    Liu J; Xu J; Li H; Sun C; Yu L; Li Y; Shi C; Zhou X; Bian X; Ping Y; Wen Y; Zhao S; Xu H; Ren L; An T; Wang Q; Yu S
    Oncotarget; 2015 Oct; 6(30):29129-42. PubMed ID: 26320176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux.
    Wen ZP; Zeng WJ; Chen YH; Li H; Wang JY; Cheng Q; Yu J; Zhou HH; Liu ZZ; Xiao J; Chen XP
    J Exp Clin Cancer Res; 2019 Jul; 38(1):298. PubMed ID: 31291988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TUBA1C is a potential new prognostic biomarker and promotes bladder urothelial carcinoma progression by regulating the cell cycle.
    Jiang Y; Zhu C; Huang H; Huang G; Fu B; Xi X
    BMC Cancer; 2023 Aug; 23(1):716. PubMed ID: 37528357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleolar and spindle-associated protein 1 is a tumor grade correlated prognosis marker for glioma patients.
    Zhu T; Xie P; Gao YF; Huang MS; Li X; Zhang W; Zhou HH; Liu ZQ
    CNS Neurosci Ther; 2018 Mar; 24(3):178-186. PubMed ID: 29336114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of ADAMDEC1 inhibits the progression of glioma in vitro.
    Liu X; Huang H; Li X; Zheng X; Zhou C; Xue B; He J; Zhang Y; Liu L
    Histol Histopathol; 2020 Sep; 35(9):997-1005. PubMed ID: 32378728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic role of SOX9 expression in human malignant glioma.
    Wang L; He S; Yuan J; Mao X; Cao Y; Zong J; Tu Y; Zhang Y
    Med Oncol; 2012 Dec; 29(5):3484-90. PubMed ID: 22714060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated expression of TUBA1C in breast cancer predicts poor prognosis.
    Zhao Y; Wang W; Li J; Du J; Xie Q; Wang M; Liu Z; Huo X; Zhao F; Ren D; Zhao J; Shen G
    PLoS One; 2023; 18(11):e0263710. PubMed ID: 38032902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAICS is related to glioma grade and can promote glioma growth and migration.
    Du B; Zhang Z; Di W; Xu W; Yang L; Zhang S; He G; Yang R; Wang M
    J Cell Mol Med; 2021 Aug; 25(16):7720-7733. PubMed ID: 34173716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Expression of Pirh2 is Associated with Poor Prognosis in Glioma.
    Bao Y; Wu X; Yuan D; Shi W; Shi J
    Cell Mol Neurobiol; 2017 Nov; 37(8):1501-1509. PubMed ID: 28258514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100A11 Promotes Glioma Cell Proliferation and Predicts Grade-Correlated Unfavorable Prognosis.
    Wang H; Yin M; Ye L; Gao P; Mao X; Tian X; Xu Z; Dai X; Cheng H
    Technol Cancer Res Treat; 2021; 20():15330338211011961. PubMed ID: 33902363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.